Healthcare Equipment and Supplies
Company Overview of Lumenis Ltd.
Lumenis Ltd., together with its subsidiaries, develops and commercializes energy-based medical systems for use in minimally invasive procedures worldwide. It operates through three segments: Surgical, Ophthalmic, and Aesthetic. The Surgical segment offers surgical laser systems and accessories used for urology/genitourinary and ENT to hospitals, outpatient clinics, ambulatory surgery centers, and medical practices. The Ophthalmic segment sells ophthalmology laser systems and accessories, such as laser links, slit lamp microscopes, laser indirect ophthalmoscopes, physician eye safety filters, surgical laser probes, and others to ophthalmic practices, outpatient clinics, and ophthalmology depa...
Yokneam Industrial Park
PO Box No. 240
Founded in 1991
Key Executives for Lumenis Ltd.
Vice President of Global Operations
Senior Vice President and Regional President of China & APAC
Vice President and Regional President of Europe, Middle East & Africa
Compensation as of Fiscal Year 2015.
Lumenis Ltd. Key Developments
Lumenis Ltd. Unveils New UltraPulse DUO CO2 Laser System and New FemTouch Solution
Nov 27 15
Lumenis Ltd. has announced unveiled its new UltraPulse DUO CO2 laser system and the new FemTouch solution. UltraPulse DUO is the newest addition to the Lumenis CO2 laser family, and provides gynecologists and fertility experts with an ultra-precise CO2 laser solution for the treatment of selected fertility related indications. The unique energy delivery is based on high level of control over each single pulse, which leads to uncompromised precision, and translates to excellent clinical outcomes. UltraPulse DUO is an innovative computer-controlled, user-friendly CO2 laser platform, which provides high energy transmission for reproducible laser-tissue interaction. The system is designed to deliver the CO2 laser energy via an articulated arm or through a Lumenis laser fiber. The advanced fiber used either in robotic surgery or with specially designed gynecology laparoscopic handpieces, is durable, flexible and with a renewable tip. In addition, the aiming beam helps assure accurate positioning and targeting of the desired tissue with excellent visualization of the surgical plane. In addition to the advanced UltraPulse DUO system, Lumenis expands its laser solutions to vaginal health conditions, with the launch of FemTouch. FemTouch was developed in collaboration with leading gynecologists and addresses vaginal health conditions by promoting the remodeling of the vaginal wall. The treatment with FemTouch can be performed as an office procedure; it is fast, simple and does not require anesthesia and virtually no post-procedural care. Preliminary reports from patients and physicians indicate that the treatment is associated with very minimal discomfort for patients, and that women being treated with FemTouch reported improvement in their condition after one to two procedures. FemTouch is offered as an add-on to Lumenis' AcuPulse product family.
Lumenis Ltd.(NasdaqGS:LMNS) dropped from NASDAQ Composite Index
Oct 12 15
Lumenis Ltd. will be removed from Nasdaq Composite Index.
Lumenis Introduces the New Pulse(TM) 100H and Pulse(TM) 50H Holmium Laser Systems
Oct 1 15
Lumenis Ltd. announced the launch of Lumenis Pulse(TM) 100H and Lumenis Pulse(TM) 50H at the 33rd World Congress of Endourology (WCE), taking place October 1 - 4, 2015 in London, UK. The Lumenis Pulse 100H, the next generation of the VersaPulse(R) PowerSuite(TM) 100 Watt system, is a versatile and enhanced laser solution for the treatment of a wide array of clinical urologic indications including benign prostatic hyperplasia (BPH), stones, tumors or strictures, along with a range of other specialties such as general surgery, ENT, gynecology and pulmonary surgery. As a greatly effective laser system for stones and BPH, the Pulse 100H enables users to perform holmium laser enucleation of the prostate (HoLEP), the gold standard treatment for BPH, and stone dusting(TM). The new system features an improved design to enhance patient safety and overall user experience. It offers a robust combination of laser parameters addressing more than 70 types of procedures, an innovative pulse reshape function for improved safety, dual pedals for improved ease of use, a hands-free ready and standby mode for minimizing cost per procedure, and a high energy per pulse of up to 3.5J with a high repetition rate of up to 50Hz. In addition to the Pulse 100H, Lumenis will also be unveiling another key addition to the Lumenis Pulse laser family, the Pulse 50H laser system. Designed to efficiently address any type or size of stone in lithotripsy, the Pulse 50H system is a superior comprehensive solution that provides 0.2J of energy per pulse to minimize migration of even the smallest stone. Furthermore, the Pulse 50H can be later upgraded to the new Pulse 100H, allowing physicians to further leverage their investment as they grow their practice.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 2, 2015
June 18, 2015